Aarti Pharmalabs Ltd
Aarti Pharma | 543748
Stock Performance
Ratios
About Company
- Aarti Pharmalabs Limited was initially incorporated as 'Aarti Organics Limited' in 2019
- The name of the Company was changed to Aarti Pharmachem Limited from Aarti Organics Limited' in July, 2021 and to Aarti Pharmalabs Limited in 2022
- Company is a manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives situated in India
- It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anti-cancer, Anti-Asthma, Anti-Hypertensive etc
- In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016
- It expanded block for CSD, Vapi and API, Tarapur units in 2022
- In 2021-22, the Pharmaceutical Division was demerged from Aarti Industries Limited into its wholly owned subsidiary, Aarti Pharmalabs Limited, via Scheme of Arrangement for Demerger, thus making it effective on October 17, 2022 and operational from July 1, 2021
- Thereafter, Company commercialised Block V at Tarapur Unit 4
- Again, it enhanced Xanthine capacity to 5,000 TPA in 2023
- The R&D centre in Nerul, Navi Mumbai became fully operational in FY 2024
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
No Information Available
Company information is not available at this time.
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Frequently Asked Questions
What is Share Price of Aarti Pharmalabs Ltd?
The current share price of Aarti Pharmalabs Ltd (Aarti Pharma) is ₹729.00. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Aarti Pharmalabs Ltd?
The Price-to-Earnings (P/E) ratio of Aarti Pharmalabs Ltd is 729.00. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Aarti Pharmalabs Ltd?
Aarti Pharmalabs Ltd has a 52-week high of ₹971.00 and a 52-week low of ₹557.05. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Aarti Pharmalabs Ltd?
Aarti Pharmalabs Ltd offers a dividend yield of 0.70%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Aarti Pharmalabs Ltd?
The Earnings Per Share (EPS) of Aarti Pharmalabs Ltd is ₹26.45. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Aarti Pharmalabs Ltd?
Aarti Pharmalabs Ltd has a Return on Equity (ROE) of 14.85%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
